Search Follow us

HBM Healthcare Investments (HBMN)

Business description

HBM Healthcare Investments (previously HBM BioVentures, renamed in 2012) aims to generate long-term gains through investment in private and public companies in the human medicine, biotech, medtech and diagnostics sectors, and related areas. It invests worldwide, predominantly in private companies, either directly or through funds, and many of its publicly listed holdings began as private equity investments.

Stock data

Market cap.€1174.9m
Last close€168.80
High / Low (52 weeks)€184.0 / €135.2
Stock market listingSW
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment trusts

Other companies in sector Show

Aberdeen Asian Income Fund Aberdeen Latin American Income Fund
Aberdeen New Dawn Investment Trust Aberdeen New Thai Investment Trust
Aberdeen Private Equity Fund Aberdeen Standard Equity Income Trust
Aberdeen UK Tracker Trust AcenciA Debt Strategies
Acorn Income Fund Adamas Finance Asia
Alliance Trust Altamir SCA
Amphion Innovations Atlantis Japan Growth Fund
Aurelius Bailador Tech Investments
Baker Steel Resources Trust Bankers Investment Trust (The)
BB Biotech BioPharma Credit
BlackRock Emerging Europe BlackRock Greater Europe Investment Trust
BlackRock Hedge Selector BlackRock Latin American Inv. Trust
BMO Managed Portfolio Trust Growth Portfolio BMO Managed Portfolio Trust Income Portfolio
British Portfolio Trust Brunner Investment Trust (The)
Canadian General Investments Carador Income Fund
CFP Sanford DeLand Free Spirit Fund. Charles Stanley
City Natural Resources Conversus Capital
CQS Rig Finance Fund CVC Credit Partners European Opps
Detour Gold Deutsche Beteiligungs
Dexion Commodities Diverse Income Trust (The)
DouglasBay Capital Dunedin Enterprise Investment Trust
DW Catalyst Fund Edinburgh Worldwide Investment Trust (The)
EJF Investments European Assets Trust
F&C Investment Trust Fidelity Asian Values
Fidelity China Special Situations Fidelity European Values
Fidelity Japan Trust Fidelity Special Values
Finsbury Growth & Income Trust Gartmore Growth Opportunities
Gartmore Irish Growth Fund Geiger Counter Limited
Genesis Emerging Markets Fund GLI Alternative Finance
Global Resources Investment Trust Golden Prospect Precious Metals
Gulf Investment Fund Hansa Trust
HarbourVest Global Private Equity HarbourVest Senior Loans Europe
Heliad Equity Partners Henderson Alternative Strategies Trust
Henderson Far East Income Henderson Global Trust
Henderson Global Trust Henderson International Income Trust
Heptagon HSBC Infrastructure Company
Infrastructure India International Biotechnology Trust
Invesco Asia Trust Invesco Income Growth Trust
Is Private Equity JP Morgan Private Equity Limited
JPMorgan Brazil Investment Trust JPMorgan European Smaller Companies Trust
JPMorgan Global Convertibles Income Fund JPMorgan Global Growth & Income
JPMorgan Indian Investment Trust Jupiter Green Investment Trust
Jupiter UK Growth Investment Trust Jupiter US Smaller Companies
JZ Capital Partners Limited Lazard World Trust Fund
Leaf Clean Energy Company LMS Capital
Lowland Investment Company LPeC
Marble Point Loan Financing Martin Currie Asia Unconstrained Trust
Martin Currie Global Portfolio Trust Middlefield Canadian Income
Miton Global Opportunities Miton Income Opportunities Trust
Murray Income Trust Murray International Trust
New City Energy Ocean Wilsons Holdings
Odyssean Investment Trust Pacific Assets Trust
Phaunos Timber Fund Polar Capital Global Financials Trust
Polar Capital Global Healthcare Trust Princess Private Equity Holding
PXP Vietnam Fund Rathbone Brothers
RENN Universal Growth Investment Trust Schroder AsiaPacific Fund
Schroder Global Real Estate Securities ScotGems
Scottish Oriental Smaller Companies Sealand Capital Galaxy
Securities Trust of Scotland Seneca Global Income & Growth Trust
Sigma Capital Group Standard Life Investments Property Income Trust
Standard Life Private Equity Trust Standard Life UK Smaller Companies
Strategic Equity Capital Taiwan Fund (The)
Templeton Emerging Markets Investment Trust Tetragon Financial Group
The Biotech Growth Trust The European Investment Trust
The Global Sustainability Trust The Law Debenture Corporation
The Merchants Trust The North American Income Trust
The Scottish Investment Trust Tiso Blackstar Group
Toscafund Asset Management TR European Growth Trust
UK Commercial Property REIT Utilico Emerging Markets Trust
Vietnam Enterprise Investments Vietnam Holding Asset Management
Vietnam Infrastructure Fund VinaCapital Vietnam Opportunity Fund
VinaLand Vision Opportunity China Fund
Volta Finance WAM Active
WAM Capital WAM Research
Witan Investment Trust Witan Pacific Investment Trust
Worldwide Healthcare Trust YFM Equity Partners

Company news

BRIEF-HBM Healthcare Investments: Eli Lilly Announces Tender Offer For HBM ...

Fri, 11 May 2018 04:41:15 GMT

1mg raises $15 million in funding round led by HBM Healthcare

Wed, 26 Jul 2017 19:07:30 GMT

1mg raises funds from HBM Healthcare

Mon, 30 May 2016 20:03:06 GMT

Vitaeris Announces Seed Financing and Appointment of Executive Team

Mon, 06 Jun 2016 19:52:30 GMT

Novartis Is Said to Consider Acquisition of Advanced Accelerator

Wed, 27 Sep 2017 21:11:15 GMT

Investment summary

HBM Healthcare Investments (HBMN) has reported extremely strong results for the first half of FY19 (to 30 September), with net earnings of CHF177m. While market conditions have turned negative in October, HBMN’s portfolio of private investments (c 36% of the total) and a market hedge covering c 20% of the listed portfolio should help to limit NAV volatility if the sell-off is prolonged. Results have been buoyed by good clinical data and a number of successful IPOs from the private portfolio, and HBMN’s managers are focused on finding new private opportunities to replace those now in the public portfolio. Ten new investments in H119 were diversified by clinical focus and geography (US, Europe and Asia). HBMN’s shares have re-rated substantially over the past year, arguably as a result of the ongoing evidence of successful execution of its strategy, as well as the high distribution policy (c 5% of NAV paid out each year).

Last updated on 29/10/2018

Key management

Andreas Wicki, CEO
Erwin Troxler, CFO

Company address

Bundesplatz 1
P.O. Box 1145
Zug
CH-6301
Switzerland
View website